Zhang Y, Liu X, Li S, Lin C, Ye Q, Wang Y, et al. Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation:
Lu M, Salgia R, Li J, et al. Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C. J Viral Hepat 2023;30:746–755. DOI:
Huang D, Tran A, Yeh ML, Yasuda S, Tsai PC, Pei-Chien H, et al. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis
Chun HS, Papatheodoridis GV, Lee M, Lee HA, Kim YH, Kim SH, Oh YS, Park SJ, Kim J, Lee HA, Kim HY, Kim TH, Yoon
Thompson A, Jackson K, Bonanzinga S, Hall S, Hume S, Burns G, Sundararajan V, et al. Hepatology Communications 7(8), August 2023. DOI: 10.1097/HC9.0000000000000188 Δείτε ΕΔΩ
Jae Seung Lee, Chan-Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim. Comparison of decline in renal function between patients
